Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD – Get Free Report) was the target of a significant increase in short interest in January. As of January 15th, there was short interest totaling 543,357 shares, an increase of 19.6% from the December 31st total of 454,448 shares. Currently, 15.3% of the company’s stock are short sold. Based on an average trading volume of 2,967,702 shares, the short-interest ratio is presently 0.2 days. Based on an average trading volume of 2,967,702 shares, the short-interest ratio is presently 0.2 days. Currently, 15.3% of the company’s stock are short sold.
Hedge Funds Weigh In On Direxion Daily S&P Biotech Bear 3x Shares
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Jump Financial LLC grew its position in shares of Direxion Daily S&P Biotech Bear 3x Shares by 107.7% during the second quarter. Jump Financial LLC now owns 174,239 shares of the company’s stock worth $1,303,000 after buying an additional 90,333 shares in the last quarter. BNP Paribas Financial Markets acquired a new position in Direxion Daily S&P Biotech Bear 3x Shares during the 3rd quarter worth approximately $5,063,000. Group One Trading LLC acquired a new position in Direxion Daily S&P Biotech Bear 3x Shares during the 2nd quarter worth approximately $337,000. Tower Research Capital LLC TRC increased its position in shares of Direxion Daily S&P Biotech Bear 3x Shares by 87.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 41,202 shares of the company’s stock valued at $308,000 after purchasing an additional 19,276 shares during the last quarter. Finally, Qube Research & Technologies Ltd acquired a new stake in shares of Direxion Daily S&P Biotech Bear 3x Shares in the 3rd quarter valued at $983,000.
Direxion Daily S&P Biotech Bear 3x Shares Stock Up 5.6%
Direxion Daily S&P Biotech Bear 3x Shares stock opened at $18.91 on Thursday. Direxion Daily S&P Biotech Bear 3x Shares has a twelve month low of $16.25 and a twelve month high of $160.50. The stock’s fifty day simple moving average is $20.13 and its 200-day simple moving average is $36.09.
Direxion Daily S&P Biotech Bear 3x Shares Company Profile
The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion.
Featured Stories
- Five stocks we like better than Direxion Daily S&P Biotech Bear 3x Shares
- The day the gold market broke
- Buy this Gold Stock Before May 2026
- Trump Planning to Use Public Law 63-43: Prepare Now
- Forget AI, This Will Be the Next Big Tech Breakthrough
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Direxion Daily S&P Biotech Bear 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bear 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
